A few facts that I learned during my visit to Kuwait; 1) gas is the fifth cheapest in the world, 2) the temperature can get hot enough to melt your tires, and 3) the region has excellent healthcare resources.
A local distributor, MedVision, is looking to bring hyperthermia to Kuwait and the surrounding region. MedVision, a division of SADITA Holdings Group, is considered one of the fast-growing companies in this field. Established in 2010, they are considered the market leaders in the territory, representing well-known companies in cardiology, cardiac surgery, and peripheral intervention.
Physicians gathered at the Kuwait Cancer Center to learn about advancements in hyperthermia. In addition to Mark Falkowski's Pyrexar's product overview presentation, MedVision invited hyperthermia expert and Director of the division of Translational Radiation Sciences at the University of Maryland School of Medicine, Dr. Zeljko Vujaskovic.
Ali Rabie, Senior Product Specialist, MedVision | Mark Falkowski, CEO - Pyrexar Medical | Ahmed El Ghamry, Business Unit Manager, MedVision
MedVision Headquarters, Safat, Kuwait
Dr. Zeljko Vujaskovic., Director of Translational Radiation Sciences at the University of Maryland School of Medicine
Oncologist gather at Kuwait Cancer Center to hear how hyperthermia can assist them in the treatment of cancer
Dr. Vujaskovic has published more than 150 articles and book chapters on radiation therapy, radiation injury, and hyperthermia topics. He has directed national and international research collaborations and is an active participant in cooperative group trials. He maintains a busy clinical practice, with a focus on advanced treatment approaches in prostate cancer. His presentation, “Principles of Hyperthermia in Cancer Treatment,” was well received. "The more we can get oncologist engaged, the greater the chance hyperthermia will return to its place as a pillar of cancer treatment."
We are in negotiations with MedVision to become an authorized distributor for Kuwait with expansion into Qatar, Bahrain, Saudi Arabia, Lebanon, Jordan, Egypt, UAE, Oman, Iraq, & Iran.
A reminder that he ORR (Oncoradiology, Radiology, and Radiotherapy) Congress will be held in Moscow, Russia, at the Holiday Inn from February 16-17, 2018. Representing Pyrexar Medical's hyperthermia product line will be our distributor Sennewald Medizintechnik, GmbH.
The main goal of the conference is to provide a platform for radiodiagnosticians, radiotherapists, and medical physicists for education, ideas and experience exchange, discussion of actual issues, and professional communication. For the first time traditional conferences such as “Radiodiagnosis Standards in Oncology,” “Radiotherapy in Oncology,” “Medical Physics in Oncology,” “Interventional Radiology in Oncology,” “Radionuclide Therapy in Oncology” and the conference with international participation “PET in Oncology” will be considered within the same event. Also, for the first time, the conference “Ultrasonic Diagnosis in Oncology,” dedicated to the memory of Professor S. Balter will be performed, and discussion site for fundamental and theoretical problems in radiobiology will be provided.
A link to registration can be found here.